Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Mostrar másEl profesor Michele Reni es un oncólogo médico experimentado con más de 30 años de práctica con sede en Italia. Se especializa en adenocarcinoma de páncreas, cánceres gastroesofágicos y tumores del sistema nervioso central. Ha publicado más de 180 artículos sobre el tratamiento del cáncer y es el coordinador de las directrices de la Asociación Italiana de Oncología Médica (AIOM) para el tratamiento y manejo del cáncer de páncreas. También ha presidido numerosos ensayos clínicos sobre el tratamiento de pacientes con cáncer de páncreas metastásico.
Mostrar másCita con el médico | precio a consultar |
Resección rectal | $18686.74 |